Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Extension of Sildenafil in PAH (SUPER-2)
NCT00159887Phase 3Completed
- Sponsor
- Viatris
- Start
- Dec 2002
- Modality
- Small Molecules
- Countries
- 22
01
Overview
A Phase 3 trial of sildenafil in pulmonary arterial hypertension (PAH), sponsored by Viatris. Started Dec 2002; status: completed.
02
Drugs
sildenafil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT00159887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00159887.